Alejandra Davila

Autologous Ex Vivo Lentiviral Gene Therapy for Adenosine Deaminase Deficiency

Donald B. Kohn, Claire Booth, Kit L. Shaw et al. · New England Journal of Medicine · 2021 · 218 citations · Full text

Life Sciences, Immunology, Molecular Medicine +12

Clinical efficacy of gene-modified stem cells in adenosine deaminase–deficient immunodeficiency

Kit L. Shaw, Elizabeth Garabedian, Suparna Mishra et al. · Journal of Clinical Investigation · 2017 · 81 citations · Full text

Medicine, Hematology, Immunology +17

Long-term outcomes after gene therapy for adenosine deaminase severe combined immune deficiency

Bryanna Reinhardt, Omar Habib, Kit L. Shaw et al. · Blood · 2021 · 48 citations · Full text

Life Sciences, Genetics, Immunology +17

Cytoreductive conditioning intensity predicts clonal diversity in ADA-SCID retroviral gene therapy patients

Aaron Cooper, Georgia R. Lill, Kit L. Shaw et al. · Blood · 2017 · 30 citations · Full text

Medicine, Immunology, Gene Therapy +6

Lentiviral Gene Therapy with Autologous Hematopoietic Stem and Progenitor Cells (HSPCs) for the Treatment of Severe Combined Immune Deficiency Due to Adenosine Deaminase Deficiency (ADA-SCID): Results in an Expanded Cohort

Donald B. Kohn, Kit L. Shaw, Elizabeth Garabedian et al. · Blood · 2019 · 16 citations

Pharmacy, Hematology, Immunology +16